Hey there,
It's Randy, here at the Super Speciosa warehouse, where we're working on some amazing new products for you. One of the things we're always thinking about when we develop new products is how effective it will be, which means we pay very close attention to new scientific studies of kratom. The Food & Drug Administration (FDA) is usually a big part of that, as the federal agency responsible for regulating food and drugs.
A little background: the FDA historically hasn't been so fond of kratom, avoiding hands-on research but also not banning it outright. Finally, last spring, the FDA worked with contract and academic researchers to conduct their very first serving size study on the kratom. They used Super Speciosa's kratom, Signature Reserve Capsules, to be exact, to conduct their research.
Why our kratom, you might ask? We're committed to providing the purest, highest-quality, and most consistent kratom you can get. And our quality shows up in the results: even though subjects were given up to 5 times the recommended amount of kratom, there were no serious adverse effects experienced by the testers.
I gotta say, I'm seriously proud of the crew here at Super Speciosa. The fact that our kratom was picked for the FDA's first round of research? That's no small thing. It really shows the kind of quality we stand behind, and it gives me hope for what the future of kratom could look like.
To learn more about our involvement in the study, read our blog here.
As always, if you have any questions, just respond to this email and I'll get back to you.
Take it easy,
Randy
Randy
| You received this email from Super Organics. If you would like to unsubscribe, click here. |
